Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Steinberg

Showing results (1071-1080 of 1,520) with videos related to

Pageof 152
Sort By:
Blood|September 26, 2000
An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virusC B Foster, T Lehrnbecher, S Samuels, et al.
Journal of Pediatric Hematology/Oncology|September 10, 2002
Treatment of metastatic osteosarcoma with the somatostatin analog OncoLar: significant reduction of insulin-like growth factor-1 serum levelsPatrick J Mansky, David J Liewehr, Seth M Steinberg, et al.
Surgery|June 14, 2008
Operative management of Cushing syndrome secondary to micronodular adrenal hyperplasiaAnathea C Powell, Constantine A Stratakis, Nicholas J Patronas, et al.
Cancer|June 15, 1996
Phase II trial of 5-fluorouracil, leucovorin, interferon-alpha-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinomaB K Temeck, J E Liebmann, C Theodossiou, et al.
Cancer|August 1, 1995
Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variablesN A Dawson, M R Cooper, W D Figg, et al.
The American Surgeon|September 15, 2010
Tree stands, not guns, are the midwestern hunter's most dangerous weaponAndrew Crockett, Stanislaw P Stawicki, Yalaunda M Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapyW H Wilson, C Jamis-Dow, G Bryant, et al.
Blood|October 22, 2014
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman diseaseThomas S Uldrick, Mark N Polizzotto, Karen Aleman, et al.
Blood|June 25, 1992
Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoidesJ W Lynch, I Linoilla, E A Sausville, et al.
Cancer|May 7, 2008
High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006Jacob A Klapper, Stephanie G Downey, Franz O Smith, et al.
Pageof 152

Showing results (1071-1080 of 1,520) with videos related to

Sort By:
Pageof 152
Blood|September 26, 2000
An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virusC B Foster, T Lehrnbecher, S Samuels, et al.
Journal of Pediatric Hematology/Oncology|September 10, 2002
Treatment of metastatic osteosarcoma with the somatostatin analog OncoLar: significant reduction of insulin-like growth factor-1 serum levelsPatrick J Mansky, David J Liewehr, Seth M Steinberg, et al.
Surgery|June 14, 2008
Operative management of Cushing syndrome secondary to micronodular adrenal hyperplasiaAnathea C Powell, Constantine A Stratakis, Nicholas J Patronas, et al.
Cancer|June 15, 1996
Phase II trial of 5-fluorouracil, leucovorin, interferon-alpha-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinomaB K Temeck, J E Liebmann, C Theodossiou, et al.
Cancer|August 1, 1995
Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variablesN A Dawson, M R Cooper, W D Figg, et al.
The American Surgeon|September 15, 2010
Tree stands, not guns, are the midwestern hunter's most dangerous weaponAndrew Crockett, Stanislaw P Stawicki, Yalaunda M Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapyW H Wilson, C Jamis-Dow, G Bryant, et al.
Blood|October 22, 2014
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman diseaseThomas S Uldrick, Mark N Polizzotto, Karen Aleman, et al.
Blood|June 25, 1992
Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoidesJ W Lynch, I Linoilla, E A Sausville, et al.
Cancer|May 7, 2008
High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006Jacob A Klapper, Stephanie G Downey, Franz O Smith, et al.
Pageof 152